Antibody Validation for Protein Expression on Tissue Slides: a Protocol for Immunohistochemistry

Overview

Journal Biotechniques

Specialties Biomedical Engineering
Biotechnology

Date 2020 Aug 28

PMID 32852223

Citations 27

Authors

Tyler MacNeil

Ioannis A Vathiotis

Sandra Martinez-Morilla

Vesal Yaghoobi

Jon Zugazagoitia

Yuting Liu

David L Rimm

Affiliations

Soon will be listed here.

Abstract

Antibodies play a crucial role in basic research and clinical decision-making. However, there are no standardized algorithms or guidelines to ensure their accuracy and validity. There have been efforts to generate consensus, but, with the exception of clinical labs, antibody validation remains variable in the literature and sometimes in clinical practice. Here we focus on immunohistochemistry, an example of a scientific and clinical tool where validation of antibodies is critical. We describe a protocol that we use to validate antibodies specifically for immunohistochemistry, including some of the pillars of antibody validation from Uhlen 2016, as an example of a rigorous approach to build antibody-based tests for both basic and translational science labs and for the clinic.

Citing Articles

Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma.

Stormoen D, Lehn S, Mouw K, Szallasi Z, Melchior L, Dohn L Sci Rep. 2024; 14(1):27448.

PMID: 39523403 PMC: 11551215. DOI: 10.1038/s41598-024-79334-x.

BCAM (basal cell adhesion molecule) protein expression in different tumor populations.

Burela S, He M, Trontzas I, Gavrielatou N, Schalper K, Langermann S Discov Oncol. 2024; 15(1):381.

PMID: 39207605 PMC: 11362396. DOI: 10.1007/s12672-024-01244-1.

Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer With a High-Sensitivity Assay.

Liu M, Vathiotis I, Robbins C, Chan N, Moutafi M, Burela S Mod Pathol. 2024; 37(9):100556.

PMID: 38964502 PMC: 11416319. DOI: 10.1016/j.modpat.2024.100556.

Validation of an organ mapping antibody panel for cyclical immunofluorescence microscopy on normal human kidneys.

Brewer M, Migas L, Clouthier K, Allen J, Anderson D, Pingry E Am J Physiol Renal Physiol. 2024; 327(1):F91-F102.

PMID: 38721662 PMC: 11390132. DOI: 10.1152/ajprenal.00426.2023.

Detecting Human Epidermal Growth Factor Receptor 2 (HER2) Amplification: Proof of Concept of an Alternative Approach.

Mudgal S, Paul P, Ravi B, Agrawal S, Kalra A, Rao S Cureus. 2023; 15(9):e44785.

PMID: 37809181 PMC: 10558136. DOI: 10.7759/cureus.44785.

References

Bradbury A, Pluckthun A . Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents. Protein Eng Des Sel. 2015; 28(10):303-5. DOI: 10.1093/protein/gzv051. View

Sfanos K, Yegnasubramanian S, Nelson W, Lotan T, Kulac I, Hicks J . If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease. Asian J Urol. 2019; 6(1):10-25. PMC: 6363603. DOI: 10.1016/j.ajur.2018.11.006. View

Andersson S, Sundberg M, Pristovsek N, Ibrahim A, Jonsson P, Katona B . Insufficient antibody validation challenges oestrogen receptor beta research. Nat Commun. 2017; 8:15840. PMC: 5501969. DOI: 10.1038/ncomms15840. View

Gustavson M, Rimm D, Dolled-Filhart M . Tissue microarrays: leaping the gap between research and clinical adoption. Per Med. 2018; 10(5):441-451. DOI: 10.2217/pme.13.42. View

Bandrowski A, Brush M, Grethe J, Haendel M, Kennedy D, Hill S . The Resource Identification Initiative: A Cultural Shift in Publishing. Neuroinformatics. 2015; 14(2):169-82. PMC: 5072392. DOI: 10.1007/s12021-015-9284-3. View

Freedman L, Gibson M, Bradbury A, Buchberg A, Davis D, Dolled-Filhart M . [Letter to the Editor] The need for improved education and training in research antibody usage and validation practices. Biotechniques. 2016; 61(1):16-8. DOI: 10.2144/000114431. View

Yaghoobi V, Martinez-Morilla S, Liu Y, Charette L, Rimm D, Harigopal M . Advances in quantitative immunohistochemistry and their contribution to breast cancer. Expert Rev Mol Diagn. 2020; 20(5):509-522. DOI: 10.1080/14737159.2020.1743178. View

Hicks D, Kulkarni S . HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol. 2008; 129(2):263-73. DOI: 10.1309/99AE032R9FM8WND1. View

Bourbeillon J, Orchard S, Benhar I, Borrebaeck C, de Daruvar A, Dubel S . Minimum information about a protein affinity reagent (MIAPAR). Nat Biotechnol. 2010; 28(7):650-3. DOI: 10.1038/nbt0710-650. View

10.

Fitzgibbons P, Bradley L, Fatheree L, Alsabeh R, Fulton R, Goldsmith J . Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med. 2014; 138(11):1432-43. DOI: 10.5858/arpa.2013-0610-CP. View

11.

Camp R, Chung G, Rimm D . Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002; 8(11):1323-7. DOI: 10.1038/nm791. View

12.

Hewitt S, Baskin D, Frevert C, Stahl W, Rosa-Molinar E . Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays. J Histochem Cytochem. 2014; 62(10):693-7. PMC: 4212362. DOI: 10.1369/0022155414545224. View

13.

Hsi E . A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med. 2001; 125(2):289-94. DOI: 10.5858/2001-125-0289-APAFEN. View

14.

Nearchou I, Lillard K, Gavriel C, Ueno H, Harrison D, Caie P . Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer. Cancer Immunol Res. 2019; 7(4):609-620. DOI: 10.1158/2326-6066.CIR-18-0377. View

15.

Baker M . Antibody anarchy: A call to order. Nature. 2015; 527(7579):545-51. DOI: 10.1038/527545a. View

16.

Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J . Antibody validation. Biotechniques. 2010; 48(3):197-209. PMC: 3891910. DOI: 10.2144/000113382. View

17.

Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E . A proposal for validation of antibodies. Nat Methods. 2016; 13(10):823-7. PMC: 10335836. DOI: 10.1038/nmeth.3995. View

18.

Runcie K, Budman D, John V, Seetharamu N . Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Mol Med. 2018; 24(1):50. PMC: 6154901. DOI: 10.1186/s10020-018-0051-4. View

19.

Kanchiswamy C, Maffei M, Malnoy M, Velasco R, Kim J . Fine-Tuning Next-Generation Genome Editing Tools. Trends Biotechnol. 2016; 34(7):562-574. DOI: 10.1016/j.tibtech.2016.03.007. View

20.

Herkenham M, Rathore P, Brown P, Listwak S . Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies. J Neuroinflammation. 2011; 8:141. PMC: 3210105. DOI: 10.1186/1742-2094-8-141. View